1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Pharmaceutical Continuous Manufacturing Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Pharmaceutical Continuous Manufacturing Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Pharmaceutical Continuous Manufacturing Market Regional Analysis
6.2 North America Pharmaceutical Continuous Manufacturing Market Revenue 2016-2027 (US$ Million)
6.3 North America Pharmaceutical Continuous Manufacturing Market Forecast Analysis
7. North America Pharmaceutical Continuous Manufacturing Market Analysis – by Product
7.1 Integrated Systems
- 7.1.1 Overview
- 7.1.2 Integrated Systems: North America Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast, 2016-2027 (US$ Million)
7.2 Semi-Continuous Systems
- 7.2.1 Overview
- 7.2.2 Semi-Continuous Systems: North America Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast, 2016-2027 (US$ Million)
7.3 Controls
- 7.3.1 Overview
- 7.3.2 Controls: North America Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast, 2016-2027 (US$ Million)
8. North America Pharmaceutical Continuous Manufacturing Market Analysis – by Application
8.1 End Product Manufacturing
- 8.1.1 Overview
- 8.1.2 End Product Manufacturing: North America Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.2 API Manufacturing
- 8.2.1 Overview
- 8.2.2 API Manufacturing: North America Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast, 2016-2027 (US$ Million)
9. North America Pharmaceutical Continuous Manufacturing Market Analysis – by End User
9.1 Full-Scale Manufacturing Companies
- 9.1.1 Overview
- 9.1.2 Full-Scale Manufacturing Companies: North America Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast, 2016-2027 (US$ Million)
9.2 R&D Departments
- 9.2.1 Overview
- 9.2.2 R&D Departments: North America Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast, 2016-2027 (US$ Million)
10. North America Pharmaceutical Continuous Manufacturing Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Pharmaceutical Continuous Manufacturing Market Breakdown, by Key
Country, 2019 and 2027 (%)
- 10.2.1.1 North America Pharmaceutical Continuous Manufacturing Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 US: North America Pharmaceutical Continuous Manufacturing Market Breakdown, by Product
- 10.2.1.1.2 US: North America Pharmaceutical Continuous Manufacturing Market Breakdown, by Application
- 10.2.1.1.3 US: North America Pharmaceutical Continuous Manufacturing Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Canada: North America Pharmaceutical Continuous Manufacturing Market Breakdown, by Product
- 10.2.1.2.2 Canada: North America Pharmaceutical Continuous Manufacturing Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Pharmaceutical Continuous Manufacturing Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Mexico : North America Pharmaceutical Continuous Manufacturing Market Breakdown, by Product
- 10.2.1.3.2 Mexico : North America Pharmaceutical Continuous Manufacturing Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North America Pharmaceutical Continuous Manufacturing Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Munson Machinery Co., Inc.,
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 THERMO FISHER SCIENTIFIC INC.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 GEA Group
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Coperion GmbH
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Gericke AG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For North America Pharmaceutical Continuous Manufacturing Market
